The popularity of Sildenafil initially sparked a boom for the drug industry, but recent changes present a murky scenario for shareholders. Lower-cost competitors are eroding earnings, and continued legal battles add https://jimomrc597901.gynoblog.com/39942700/sildenafil-and-the-pharmaceutical-industry-a-volatile-bet